What You Should Know:
- ALZpath, a developer of blood-based diagnostic biomarker testing for Alzheimer's disease detection receives funding from the Alzheimer’s Drug Discovery Foundation (ADDF)’s Diagnostics Accelerator to accelerate the clinical availability of ALZpathDx as a laboratory developed test (LDT).
- ALZpathDx is a novel, proprietary assay for blood-based measurement of phosphorylated tau at threonine 217 (pTau217), a highly accurate, diagnostic biomarker for
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
SiPhox Health Secures $27M for Lab-Grade Home Health Testing with Silicon Photonics
What You Should Know:
- Today, SiPhox Health, a Burlington, MA-based company building the next generation of lab-grade home health testing with silicon photonics raises $27M in funding, including a $10M Seed led by Khosla Ventures and Y Combinator, and a $17M Series A led by Intel Capital.
- The SiPhox Home and Health testing systems offer innovative and efficient blood collection solutions for consumers, healthcare systems, pharmaceutical companies, and research teams focusing on
Read More
The Problem With Modern Disinfectants & What The Future of Infection Protection Should Look Like
Keeping surfaces pathogen-free is crucial in preventing the transmission of diseases and infections. Pathogens are microorganisms that can cause illness, and they can easily spread from contaminated surfaces to people who come into contact with those surfaces. This is a major concern in healthcare settings such as hospitals, where pathogens can spread easily and cause infections in vulnerable patients. In addition, pathogen spread can also occur in public places such as schools, workplaces, and
Read More
Eli Lilly Acquires Obesity Drug Maker Versanis for $1.9B
What You Should Know:
Eli Lilly announced an agreement to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases for $1.925B in cash. Versanis' lead asset is bimagrumab, a monoclonal antibody that binds activin type II A and B receptors to block activin and myostatin signaling. Bimagrumab is currently being assessed in the BELIEVE Phase 2b study alone and in combination with
Read More
Causaly Secures $60M to Accelerate AI-Powered Biomedical Research
What You Should Know:
Causaly, the leading AI platform for biomedical research raises $60M in Series B funding led by ICONIQ Growth, with participation from Index Ventures, Marathon Venture Capital, EBRD, Pentech Ventures and Visionaries Club. Strategic individuals also participated in the round, including Alex Gorsky (former Chairman and CEO of Johnson & Johnson) and Olivier Pomel (CEO and Co-Founder of Datadog). The investment brings the total funding raised to $93 million,
Read More
Israel Innovation Authority to Invest $31M to Establish R&D Infrastructure Center for Bio-Chips-Based Bio-Devices
What You Should Know:
The Israel Innovation Authority announced today a NIS 113M ($31M USD) investment for the establishment of a center that will provide research and development (R&D) infrastructure for bio-devices based on bio-chips. The investment is part of the National Bio-Convergence Program.Bio-convergence represents the integration of biology and life sciences with engineering and software technologies. The investment is directed at companies dedicated to developing key
Read More
Why PV Signal Teams Must Leverage RWD & Advanced Cognitive Computing
Signal detection — one of the most critical activities within pharmacovigilance (PV) — is the process of searching for and identifying safety signals from a variety of data sources. PV teams typically monitor safety signals for post-market products by reviewing scientific and medical literature, data obtained from clinical studies, and individual case safety reports (ICSRs).
ICSRs gather data supporting reporting adverse events (AEs), product problems, and customer complaints associated
Read More
Verily & L’Oreal Launches Diverse Skin and Hair Health Registry
What You Should Know:
Today, Verily and L’Oreal announced the launch of a multi-year study, My Skin & Hair Journey, to advance precision skin and hair health. This is part of the two companies' multi-year partnership and research collaboration. The My Skin & Hair Journey registry will enroll thousands of self-identifying U.S. women to develop an unprecedented body of knowledge about perceptions and experiences of skin and hair health, including the role of lifestyle,
Read More
Volume and Cost of Clinical Lab Tests Expected to Rise in 2023
What You Should Know:
According to a new report on lab trends, the overall number of routine lab tests declined from 2021 to 2022, largely due to a reduction in COVID-19 tests. However, the number of non-COVID tests rose during the same period and is expected to continue to grow, along with overall spending on tests.The 2023 Lab Trend Report comes from Avalon Healthcare Solutions, a Lab Insights company that provides an annual evaluation of the status of U.S. clinical lab testing and an
Read More
Abbott Receives FDA Approval for World’s First Dual Chamber Leadless Pacemaker
What You Should Know:
The U.S. Food and Drug Administration (FDA) approves Abbott’s AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system that treats people with abnormal or slow heart rhythms.Abbott’s breakthrough technology enables the world's first beat-to-beat, wireless communication and synchronization between two leadless pacemakers, which are smaller than a AAA batteryLeadless pacemakers provide a new minimally invasive option
Read More
